Ethical MedTech and the Conference Vetting System (CVS)

ethical medtech and conference vetting system

The Conference Vetting System (CVS) is a centralised decision-making system that encourages transparency and consistency in medical education events. It is an independently managed system which reviews the compliance of third-party educational events with MedTech Europe Code of Ethical Business Practice and Mecomed Code of Business Practice (the “Codes”) to determine the appropriateness for companies which are members of MedTech Europe and Mecomed to provide financial support to such events in the form of educational grants or commercial activities (booths, advertising, satellite symposium).

Members of MedTech Europe and Mecomed cannot provide support to an event that has not been prior positively assessed by CVS. Furthermore, the decisions rendered by the Compliance Officer are binding on MedTech Europe and Mecomed members. Which means that these members cannot provide support to an event which is found to be not compliant.

The CX Symposium usually seeks Ethical MedTech Compliance on an annual basis. However, due to the pandemic and the virtual status of the 2021 Symposium, we are not required to seek approval as virtual events do not need to be submitted to the CVS. The Symposium is listed on the CVS official calendar.

ethical medtech trusted partner